Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device
Top Cited Papers
- 8 December 2009
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (23) , 2352-2357
- https://doi.org/10.1161/circulationaha.108.814863
Abstract
Background— The effects of continuous blood flow and reduced pulsatility on major organ function have not been studied in detail.Keywords
This publication has 15 references indexed in Scilit:
- Renal Function After Implantation of Continuous Versus Pulsatile Flow Left Ventricular Assist DevicesThe Journal of Heart and Lung Transplantation, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- End-organ Function in Patients on Long-term Circulatory Support With Continuous- or Pulsatile-flow Assist DevicesThe Journal of Heart and Lung Transplantation, 2007
- Relation of Loop Diuretic Dose to Mortality in Advanced Heart FailurePublished by Elsevier ,2006
- Characteristics of Patients Who Die With Heart Failure and a Low Ejection Fraction in the New MillenniumJournal of Cardiac Failure, 2006
- Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart FailureClassification and Regression Tree AnalysisJAMA, 2005
- Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 monthsThe Annals of Thoracic Surgery, 2003
- Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculationThe Annals of Thoracic Surgery, 2002
- Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Abiomed BVS 5000: Experience and potential advantagesThe Annals of Thoracic Surgery, 1996